Reflecting its unequivocal commitment to leading the 503B compounded pharmaceuticals outsourcing industry in excellence, SCA Pharmaceuticals has named Abby Kaplan as General Counsel and Chief Compliance Officer.
SCA Pharma, an FDA-registered outsourcing facility, today announced that it will expand its operations in Little Rock. SCA will be investing more than $10 million and will create the opportunity to double its current Little Rock workforce of 180 people. Additionally, the investment will allow SCA Pharma to renovate an existing 42,000-square-foot facility at the Clinton National Airport and construct an additional 20,000-square-foot facility adjacent to the existing facility. SCA announced last week that it also plans a 40 percent expansion of its Windsor, Conn. facility.
“We are very pleased that as we continue our geographical expansions in both Arkansas and Connecticut, we can partner with the Arkansas Economic Development Commission (AEDC) and the Little Rock Municipal Airport Commission to solidify and expand the operations of our legacy operations,” said Milton Boyer, CEO of SCA Pharma. “Little Rock has been the foundation that has allowed for our other expansion projects, and this project will bolster that foundation for years to come.”
SCA, founded in Little Rock in 2010, has experienced significant growth over the past five years and has emerged as a leading manufacturer of compounded pharmaceuticals. The company continually seeks new opportunities to meet customer and patient needs. Creating an additional clean room capacity will provide another avenue to increase supply.
“Arkansas is committed to nurturing its homegrown companies from seed stage upward,” Gov. Asa Hutchinson said. “We are proud to see the success that SCA Pharma is experiencing and look forward to the products and services being developed here in central Arkansas that will positively impact the lives of people around the country.”
The expansion of both locations will also create the need for technical and highly skilled jobs for both areas.
“As a national leader in compounded pharmaceutical manufacturing, SCA Pharma is a great fit for this area of the state,” Arkansas Department of Commerce Secretary and Executive Director of the AEDC Mike Preston said. “The company’s decision to expand in Arkansas speaks volumes about our state’s business climate and our workforce.”
“Even in these trying and turbulent times of a global pandemic and its uncertainty, Little Rock is continuing to see companies invest and create new jobs for our citizens,” said Mayor Frank Scott Jr. “We are thrilled and grateful SCA Pharma is joining Little Rock’s momentum and creating high-paying jobs that will have a lasting impact on our economy.”
“Expansions, such as SCA Pharma, often create synergies that lead to even more opportunities,” said Chairman Gus Vratsinas, Little Rock Municipal Airport Commission. “We’re pleased to help SCA Pharma expand and create additional good paying jobs as our main focus is to make a positive economic impact.”
“We are thankful to SCA Pharma for expanding in Pulaski County and creating meaningful opportunities,” said Judge Barry Hyde. “The airport is one of our most important infrastructure assets in central Arkansas, and it is great to see new job creation come from these infrastructure assets.”
“Founded in Little Rock just 10 years ago, we are pleased SCA Pharma will be expanding where they were founded,” Little Rock Regional Chamber Chair Ronnie Dedman said. “Their expansion proves that companies are finding the right talent to succeed in Little Rock.”